{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-093007","form_type":"8-K","ticker":"LCTX","cik":"0000876343","company_name":"Lineage Cell Therapeutics, Inc.","filed_at":"2025-07-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.543789+00:00","generated_at":"2026-05-18T09:51:11.807750+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Shareholders approve 19.5M share increase to 2021 Equity Plan at annual meeting","bullets":["Shareholders approved amendment increasing common shares reserved under 2021 Equity Plan by 19,500,000.","All seven director nominees elected: Mulroy, Amin, Andrews, Russell, Bradsher, Culley, Jayasuriya.","Ratification of Baker Tilly as auditor for FY2025 received ~159M votes for, ~912K against.","Advisory say-on-pay approved with ~96M votes for, ~3.8M against, ~612K abstentions.","EIP Amendment approved with ~88.6M for, ~11.6M against, ~351K abstentions."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-093007","json":"https://secwatch.observer/filing/0000950170-25-093007.json","markdown":"https://secwatch.observer/filing/0000950170-25-093007.md","text":"https://secwatch.observer/filing/0000950170-25-093007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/876343/000095017025093007/0000950170-25-093007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/876343/000095017025093007/lctx-20250626.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T09:51:11.807750+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}